HealthEquity Debt to Equity Ratio 2014-2026 | HQY
Current and historical debt to equity ratio values for HealthEquity (HQY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. HealthEquity debt/equity for the three months ending July 31, 2026 was 0.47.
| HealthEquity Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-07-31 | $1.28B | $1.99B | 0.64 |
| 2026-04-30 | $1.26B | $2.05B | 0.62 |
| 2026-01-31 | $1.27B | $2.11B | 0.60 |
| 2025-10-31 | $1.26B | $2.13B | 0.59 |
| 2025-07-31 | $1.27B | $2.15B | 0.59 |
| 2025-04-30 | $1.29B | $2.12B | 0.61 |
| 2025-01-31 | $1.33B | $2.12B | 0.63 |
| 2024-10-31 | $1.36B | $2.13B | 0.64 |
| 2024-07-31 | $1.36B | $2.16B | 0.63 |
| 2024-04-30 | $1.15B | $2.10B | 0.55 |
| 2024-01-31 | $1.13B | $2.04B | 0.56 |
| 2023-10-31 | $1.11B | $1.99B | 0.56 |
| 2023-07-31 | $1.12B | $1.95B | 0.57 |
| 2023-04-30 | $1.12B | $1.92B | 0.58 |
| 2023-01-31 | $1.19B | $1.90B | 0.63 |
| 2022-10-31 | $1.18B | $1.88B | 0.63 |
| 2022-07-31 | $1.21B | $1.87B | 0.65 |
| 2022-04-30 | $1.21B | $1.86B | 0.65 |
| 2022-01-31 | $1.26B | $1.85B | 0.68 |
| 2021-10-31 | $1.23B | $1.87B | 0.66 |
| 2021-07-31 | $1.29B | $1.86B | 0.69 |
| 2021-04-30 | $1.31B | $1.85B | 0.71 |
| 2021-01-31 | $1.33B | $1.38B | 0.97 |
| 2020-10-31 | $1.30B | $1.36B | 0.96 |
| 2020-07-31 | $1.32B | $1.34B | 0.99 |
| 2020-04-30 | $1.52B | $1.04B | 1.46 |
| 2020-01-31 | $1.54B | $1.03B | 1.49 |
| 2019-10-31 | $1.54B | $1.02B | 1.52 |
| 2019-07-31 | $0.08B | $1.02B | 0.08 |
| 2019-04-30 | $0.07B | $0.53B | 0.13 |
| 2019-01-31 | $0.03B | $0.48B | 0.07 |
| 2018-10-31 | $0.02B | $0.46B | 0.05 |
| 2018-07-31 | $0.02B | $0.43B | 0.05 |
| 2018-04-30 | $0.02B | $0.40B | 0.05 |
| 2018-01-31 | $0.02B | $0.35B | 0.07 |
| 2017-10-31 | $0.02B | $0.33B | 0.07 |
| 2017-07-31 | $0.02B | $0.32B | 0.05 |
| 2017-04-30 | $0.01B | $0.29B | 0.04 |
| 2017-01-31 | $0.02B | $0.26B | 0.07 |
| 2016-10-31 | $0.01B | $0.25B | 0.05 |
| 2016-07-31 | $0.01B | $0.24B | 0.05 |
| 2016-04-30 | $0.01B | $0.22B | 0.04 |
| 2016-01-31 | $0.02B | $0.20B | 0.08 |
| 2015-10-31 | $0.01B | $0.20B | 0.07 |
| 2015-07-31 | $0.01B | $0.19B | 0.06 |
| 2015-04-30 | $0.01B | $0.16B | 0.07 |
| 2015-01-31 | $0.02B | $0.14B | 0.10 |
| 2014-10-31 | $0.01B | $0.14B | 0.09 |
| 2014-07-31 | $0.06B | $0.01B | 5.16 |
| 2014-04-30 | $0.00B | $0.00B | 0.00 |
| 2014-01-31 | $0.00B | 0.00 | |
| 2013-10-31 | $0.00B | $0.00B | 0.00 |
| 2013-07-31 | $0.00B | $0.00B | 0.00 |
| 2013-01-31 | $0.05B | $-0.01B | -8.25 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.983B | $1.313B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.177B | 25.78 |
| CVS Health (CVS) | United States | $120.850B | 12.05 |
| HCA Healthcare (HCA) | United States | $91.758B | 14.27 |
| Elevance Health (ELV) | United States | $90.552B | 14.21 |
| Cencora (COR) | United States | $61.693B | 18.85 |
| Natera (NTRA) | United States | $50.563B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.274B | 18.52 |
| Viatris (VTRS) | United States | $19.124B | 6.61 |
| Medpace Holdings (MEDP) | United States | $17.319B | 36.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.369B | 0.00 |
| DiDi Global (DIDIY) | China | $16.046B | 176.00 |
| Revvity (RVTY) | United States | $15.643B | 26.20 |
| Solventum (SOLV) | United States | $15.330B | 12.69 |
| ICON (ICLR) | Ireland | $13.204B | 17.94 |
| Charles River Laboratories (CRL) | United States | $13.027B | 27.56 |
| BrightSpring Health Services (BTSG) | United States | $11.642B | 40.03 |
| Avantor (AVTR) | United States | $10.443B | 18.83 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.054B | 79.17 |
| Sonic Healthcare (SKHHY) | Australia | $6.771B | 0.00 |
| PACS (PACS) | United States | $6.662B | 22.39 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.327B | 0.00 |
| MiniMed (MMED) | United States | $6.193B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.157B | 23.28 |
| Sotera Health (SHC) | United States | $5.416B | 22.33 |
| Concentras Parent (CON) | United States | $4.542B | 22.40 |
| Organon (OGN) | United States | $3.587B | 4.55 |
| GeneDx Holdings (WGS) | United States | $2.822B | 262.89 |
| CareDx (CDNA) | United States | $2.723B | 309.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.169B | 12.71 |
| Alignment Healthcare (ALHC) | United States | $2.151B | 54.58 |
| Establishment Labs Holdings (ESTA) | United States | $2.130B | 0.00 |
| Progyny (PGNY) | United States | $2.130B | 30.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.912B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.907B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.787B | 68.25 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.573B | 0.00 |
| Agilon Health (AGL) | United States | $1.547B | 0.00 |
| Ardent Health (ARDT) | United States | $1.508B | 8.62 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Nutex Health (NUTX) | United States | $1.475B | 8.45 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.204B | 245.88 |
| GoodRx Holdings (GDRX) | United States | $1.196B | 23.27 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| CryoPort (CYRX) | United States | $0.826B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.688B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.472B | 9.77 |
| Strata Critical Medical (SRTA) | United States | $0.468B | 0.00 |
| Forward Industries (FWDI) | United States | $0.449B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.382B | 5.55 |
| Shoulder Innovations (SI) | United States | $0.374B | 0.00 |
| Biodesix (BDSX) | United States | $0.292B | 0.00 |
| Embecta (EMBC) | United States | $0.288B | 2.50 |
| So-Young (SY) | China | $0.276B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.098B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.068B | 8.06 |
| Tevogen (TVGN) | United States | $0.050B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.008B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |